Item 8.01. Other Events.

Acorda Therapeutics, Inc. today announced that on June 15, 2021 it repaid in full its 1.75% Convertible Senior Notes due 2021. Prior to their maturity and repayment, there were $69.0 million aggregate principal amount of 2021 notes outstanding. The 2021 notes were repaid using cash on hand. A copy of the press release announcing the repayment is attached as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated by reference into this Item 8.01.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description
99.1            Press Release dated June 16, 2021
104           Cover Page Interactive Data File (formatted as inline XBRL and
              contained in Exhibit 101)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses